See the DrugPatentWatch profile for Sogroya
What does “Sogroya patent 2036” refer to?
Sogroya (somapacitan-beco) is a growth hormone (GH) therapy. The “patent 2036” phrasing usually means the latest/extended patent protection for Sogroya-related intellectual property in a specific country or for a specific set of claims, not a single universal date worldwide. Patent expiry timelines also vary by jurisdiction and by whether any extensions (for example, regulatory-related extensions) apply.
When does the Sogroya patent expire (2036) and where?
Patent expiry dates like “2036” depend on:
- The country (or patent family) being referenced.
- Which patent within the family is being cited (composition, formulation, use, method, etc.).
- Whether any patent term adjustments or extensions apply in that jurisdiction.
Because the underlying patent numbers and jurisdictions are not provided in your question, the exact meaning of “2036” can’t be confirmed from the information given.
How can a 2036 date change over time?
Even if a patent is listed as expiring in 2036, real-world enforceability can shift due to:
- Court rulings that invalidate a patent or narrow its claims.
- Patent settlements that change what is challenged or licensed.
- Additional related patents in the same family that may extend market exclusivity in certain forms (even if a specific patent date is 2036).
Does patent expiry mean competitors can market immediately?
Not necessarily. For biologic drugs, multiple layers can affect entry timing, including:
- Other patents that may still be in force after a particular patent expires.
- Regulatory exclusivity periods (which are separate from patent expiry).
- Litigation outcomes that may delay launch of biosimilars or generics even after a headline patent date.
Which patents are typically counted when people cite a “latest” year like 2036?
People often cite the “furthest out” protection date tied to major claim categories, such as:
- Drug substance/composition protection
- Formulation or device-related claims
- Specific therapeutic use or method-of-use claims
To pinpoint the exact 2036 reference, you’d need the patent number and jurisdiction (for example, a US patent number vs. an EP/UK/Germany/France patent).
What should you look up to verify the 2036 date?
If you’re trying to verify “Sogroya patent 2036” precisely, the key items to capture are:
- The patent publication or number that corresponds to the 2036 expiry
- The jurisdiction/country (US, EP, UK, etc.)
- Whether the date is “application filing-based,” “granted patent term,” or “extended” by local rules
- Whether there are related patents with later dates
If you share one detail, I can nail it down
If you tell me the jurisdiction (e.g., US, EU/UK, Germany) or the patent number/publication you mean, I can help interpret what that “2036” date corresponds to and how it affects potential competitor entry.